| From March 29-April 1st, ASBM will be participating in the Festival of Biologics USA, part of the World Biosimilar Congress USA 2021. The event is typically held in San Diego, CA but will be held virtually this year due to travel restrictions related to the COVID-19 pandemic.
At the event, ASBM Steering Committee Member Andrew Spiegel will moderate two panels. The first will be a keynote panel discussion entitled “Biosimilar Regulatory Reform” on March 29th.
The second will be a plenary keynote panel discussion “Biosimilar Uptake and Progress from the Healthcare Perspective”, on March 31st.
In addition, on March 31st, ASBM Advisory Board Chair Philip Schneider will moderate the closing keynote panel discussion panel: “Harnessing influence to change biosimilar policies: current programs and ideas for the future” |
